Friday, December 02, 2016 4:12:40 PM
The USPTO just confirmed that all 3 patents are still invalidated. MNTA had a quick spike and then dropped off. No change for TEVA stock either.
I think both stocks go up from here. TEVA is down from $70 to $36. It is crazy that the market thinks Teva is going to lose all of its Copaxone sales (if not, why has the stock been cut in half) and yet thinks MNTA / NVS will sell none of the 40 mg Copaxone. Otherwise, how do you explain the lack of price movement in MNTA (or NVS for that matter)?
http://seekingalpha.com/news/3228370-teva-loses-bid-revive-413-copaxone-patent-bloomberg
PS: MYL, TEVA, NVS, AZN all at 52 week lows. Anybody thinking of these stocks now?
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM